DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Zhou C. et al.
Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer
ESMO 2010; LBA 13
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.